These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6681128)

  • 21. [Effect of allopurinol on the indicators of immunity in podagra and experimental hyperuricemia].
    Siniachenko OV; Nikolenko IuI; Diadyk AI; Bortnik VA; Okushko RV
    Revmatologiia (Mosk); 1991; (1):12-5. PubMed ID: 2068454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of gout with allopurinol. (Study of 106 cases)].
    Delbarre F; Auscher C; Amor B; de Géry A
    Sem Hop; 1967 Feb; 43(10):634-43. PubMed ID: 4292982
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medical control of uric acid in patients with gout--desirable level of serum uric acid and the choice of drugs].
    Yamanaka H
    Nihon Rinsho; 1991 May; 49(5):1093-101. PubMed ID: 2067100
    [No Abstract]   [Full Text] [Related]  

  • 26. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of allopurinol in controlling hyperuricemia.
    Streiker FB
    J Am Podiatry Assoc; 1969 Mar; 59(3):87-9. PubMed ID: 5775103
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B; Olander R
    Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract]   [Full Text] [Related]  

  • 29. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
    [No Abstract]   [Full Text] [Related]  

  • 30. [Allopurinol in the treatment of gout: initial results].
    Serre H; Simon L; Claustre J
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049
    [No Abstract]   [Full Text] [Related]  

  • 31. Allopurinol in the treatment of gout.
    Woodbury JF; Mehta DM; Morse WI
    N S Med Bull; 1969 Aug; 48(4):103-7. PubMed ID: 5258764
    [No Abstract]   [Full Text] [Related]  

  • 32. Gout.
    Roddy E; Mallen CD; Doherty M
    BMJ; 2013 Oct; 347():f5648. PubMed ID: 24473446
    [No Abstract]   [Full Text] [Related]  

  • 33. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
    Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
    Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
    Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 36. [Allopurinol treatment of hyperuricemia].
    Nissen NI; Paikin H
    Nord Med; 1967 Oct; 78(41):1320-4. PubMed ID: 6054472
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The inhibition of uric acid synthesis with Allopurinol].
    Holländer E
    Orv Hetil; 1968 Oct; 109(41):2272-4. PubMed ID: 5715143
    [No Abstract]   [Full Text] [Related]  

  • 39. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
    Sundy JS; Baraf HS; Yood RA; Edwards NL; Gutierrez-Urena SR; Treadwell EL; Vázquez-Mellado J; White WB; Lipsky PE; Horowitz Z; Huang W; Maroli AN; Waltrip RW; Hamburger SA; Becker MA
    JAMA; 2011 Aug; 306(7):711-20. PubMed ID: 21846852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.